ZYBANK (01216) issues RMB 10 billion perpetual capital bonds.
ZYBANK (01216) has issued an announcement that, with the approval of the Henan Regulatory Bureau of the National Financial Regulatory Administration and the People's Bank of China, the bank recently issued the ZYBANK Co., Ltd. 2026 Undated Capital Bonds (First Tranche) in the national interbank bond market. The current tranche of bonds was bookbuilt on September 17, 2026, and payment was completed on September 21, 2026, with an issuance size of RMB 10 billion. The coupon rate for the first 5 years of the current tranche of bonds is 1.92%, adjusted every 5 years, and the bank has the right to redeem all or part of the current tranche of bonds on each interest payment date in the 5th year and thereafter. The proceeds raised from the issuance of the current tranche of bonds will be used, in accordance with applicable laws and the approval of regulatory authorities, to replenish the bank's additional tier-one capital.
ZYBANK (01216) has issued an announcement that, with the approval of the Henan Regulatory Bureau of the National Financial Regulatory Administration and the People's Bank of China, the bank recently issued ZYBANK Co., Ltd. 2026 Undated Capital Bonds (First Tranche) in the national interbank bond market. This tranche of bonds was bookbuilt on September 17, 2026, and payment was completed on September 21, 2026, with an issuance size of RMB 10 billion. The coupon rate for the first 5 years of this tranche of bonds is 1.92%, adjusted every 5 years, and the bank has the right to redeem all or part of this tranche of bonds on each interest payment date in the 5th year and thereafter. The proceeds from the issuance of this tranche of bonds will be used, in accordance with applicable laws and regulatory approvals, to replenish the bank's additional tier-one capital.
Related Articles

SKYFAME REALTY (00059) Announces 2025 Annual Results, Shareholders' Loss Attributable at RMB 201 Million, Narrowed by 95.8% Year-on-Year

GENFLEET-B (02595): The share price has risen recently; the clinical project of GFH375 combined with cetuximab combination therapy is proposed to be included in the breakthrough therapy designation list.

Coherent (COHR.US) launches PhotonLink integrated optical platform, targeting next-generation AI data centers.
SKYFAME REALTY (00059) Announces 2025 Annual Results, Shareholders' Loss Attributable at RMB 201 Million, Narrowed by 95.8% Year-on-Year

GENFLEET-B (02595): The share price has risen recently; the clinical project of GFH375 combined with cetuximab combination therapy is proposed to be included in the breakthrough therapy designation list.

Coherent (COHR.US) launches PhotonLink integrated optical platform, targeting next-generation AI data centers.

RECOMMEND





